World's Best Scientists 2026 revealed!
Haidong Dong

Haidong Dong

D-Index & Metrics

Immunology

D-Index
77
Citations
39770
World Ranking
1786
National Ranking
881

Haidong Dong publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Haidong Dong sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 285 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Haidong Dong D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Haidong Dong sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 77 D-Index — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Haidong Dong is affiliated with the Mayo Clinic in the United States and has contributed extensively to medical research, particularly focusing on immunology, oncology, and molecular biology. Their research output spans several subfields including pulmonary and respiratory medicine, as well as surgery.

The primary areas of study for Haidong Dong cover broad topics in medicine and immunology and microbiology. Specific subfields they have contributed to include:

  • Oncology
  • Immunology
  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Surgery

The main research topics in their work reflect a strong emphasis on cancer immunotherapy and biomarkers, CAR-T cell therapy, and immune responses. Additional focus areas include:

  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Immune Cell Function and Interaction
  • Immune cells in cancer
  • Extracellular vesicles in disease
  • Cholangiocarcinoma and Gallbladder Cancer Studies

Haidong Dong's frequent publication venues indicate a consistent presence in immunology and cancer research communities. These venues include:

  • The Journal of Immunology
  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Regular and Young Investigator Award Abstracts
  • Journal of Clinical Oncology

Among their recent papers are:

  • "Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma," 2020, Journal of Clinical Investigation
  • "Immune signatures underlying post-acute COVID-19 lung sequelae," 2021, Science Immunology
  • "ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression," 2022, Developmental Cell
  • "ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance," 2020, OncoImmunology
  • "Regulation of sister chromatid cohesion by nuclear PD-L1," 2020, Cell Research

Frequent collaborators in their research include:

  • Fabrice Lucien
  • Joanina K. Gicobi
  • Henan Zhang
  • Sean S. Park
  • Michelle A. Hsu

Best Publications

  • Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

    Haidong Dong;Scott E. Strome;Diva R. Salomao;Hideto Tamura

  • B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

    Haidong Dong;Gefeng Zhu;Koji Tamada;Lieping Chen

  • Exosomal PD-L1 Contributes to Immunosuppression and is Associated with anti-PD-1 Response

    Gang Chen;Alexander C. Huang;Wei Zhang;Wei Zhang;Gao Zhang

  • Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

    Unknown

  • Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

    Tyler J Curiel;Shuang Wei;Haidong Dong;Xavier Alvarez

  • B7-H3: A costimulatory molecule for T cell activation and IFN-γ production

    Andrei I. Chapoval;Jian Ni;Julie S. Lau;Ryan A. Wilcox

  • Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity

    Fumiya Hirano;Katsumi Kaneko;Hideto Tamura;Haidong Dong

  • Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

    Lieping Chen;Scott E. Strome;Eugene D. Kwon

  • Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

    R. Houston Thompson;Susan M. Kuntz;Bradley C. Leibovich;Haidong Dong

  • PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma

    R. Houston Thompson;Haidong Dong;Christine M. Lohse;Bradley C. Leibovich

  • B7-H1 Blockade Augments Adoptive T-Cell Immunotherapy for Squamous Cell Carcinoma

    Scott E. Strome;Haidong Dong;Hideto Tamura;Stephen G. Voss

  • 618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target

    R. Houston Thompson;Michael D. Gillett;John C. Cheville;Christine M. Lohse

  • PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression

    Haidong Tang;Yong Liang;Robert A. Anders;Janis M. Taube

  • B7-H1 Determines Accumulation and Deletion of Intrahepatic CD8+ T Lymphocytes

    Haidong Dong;Gefeng Zhu;Koji Tamada;Dallas B. Flies

  • B7-H1 pathway and its role in the evasion of tumor immunity

    Haidong Dong;Lieping Chen

  • Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

    Wei Ding;Betsy R. LaPlant;Timothy G. Call;Sameer A. Parikh

  • B7-H4 expression in renal cell carcinoma and tumor vasculature: Associations with cancer progression and survival

    Amy E. Krambeck;R. Houston Thompson;Haidong Dong;Christine M. Lohse

  • PD-1 Restrains Radiotherapy-Induced Abscopal Effect

    Sean S. Park;Haidong Dong;Xin Liu;Susan M. Harrington

  • Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas

    Guoying Zhou;Dave Sprengers;Patrick P.C. Boor;Michail Doukas

  • Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma

    Xavier Frigola;Brant A Inman;Christine M Lohse;Christopher J Krco

  • Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS

    Shengdian Wang;Gefeng Zhu;Andrei I. Chapoval;Haidong Dong

  • Molecular Modeling and Functional Mapping of B7-H1 and B7-DC Uncouple Costimulatory Function from PD-1 Interaction

    Shengdian Wang;Jürgen Bajorath;Jürgen Bajorath;Dallas B. Flies;Haidong Dong

  • B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function

    Hideto Tamura;Haidong Dong;Gefeng Zhu;Gabriel L. Sica

Frequent Co-Authors

Lieping Chen
Lieping Chen Yale University
John C. Cheville
John C. Cheville Mayo Clinic
Koji Tamada
Koji Tamada Yamaguchi University
Michael L. Blute
Michael L. Blute Harvard University
Ying Li
Ying Li Nanjing Agricultural University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology can open doors to various advanced healthcare roles, with many professionals seeking specialized online degrees to enhance their expertise. For those interested in mental health, exploring the cheapest online pmhnp certificate programs offers an affordable pathway to becoming a Psychiatric Mental Health Nurse Practitioner, blending immunology knowledge with patient care in mental health settings.

Nursing professionals often pursue a doctorate in nursing salary to understand the financial benefits of advancing their qualifications. This informed approach helps guide career transitions and investments in education, particularly for those targeting specialized healthcare roles informed by immunology.

For nurse practitioners aiming to expand their scope, enrolling in an fnp to acute care np bridge program facilitates a smooth transition from family to acute care settings. This pathway is ideal for professionals looking to apply immunology principles in more critical and specialized patient care areas.

Additionally, accelerated learning options such as accelerated nurse practitioner programs provide flexible timing for busy professionals to quickly gain credentials necessary for advanced roles, supporting career growth while balancing other commitments.

Best Scientists Citing Haidong Dong

Trending Scientists

Recently Published Articles